9JUN

MERS kills a third, two new Gulf cases

2 min read

09:58UTC

WHO EMRO logged two new MERS-CoV cases including one death in Saudi Arabia since 4 May, with no sustained human-to-human transmission and EU risk rated very low.

← Back to Ebola outbreak gets an R0, and a fork Jump to analysis ↓

ScienceDeveloping

Key takeaway

A coronavirus that kills around a third of cases stays watched even when transmission stays sporadic.

The WHO Eastern Mediterranean Regional Office (EMRO), WHO's regional office for the Middle East and the primary reporting body for the disease, logged two new cases of Middle East Respiratory Syndrome (MERS, the coronavirus also written MERS-CoV) since 4 May, including one death in Saudi Arabia, bringing the 2026 Saudi total to two cases and one death ¹. MERS-CoV was first identified in Saudi Arabia in 2012 and causes sporadic cases on the Arabian Peninsula, usually via camel contact. No sustained human-to-human transmission has been found, and ECDC rates the risk to the EU as very low ².

MERS earns a line for its lethality, not its spread. Its case-fatality ratio sits around 35% across the historical record, against roughly 0.1% for seasonal flu, so two cases in Saudi Arabia still warrant a surveillance note even when the transmission picture is reassuring. The threshold for concern would be evidence of person-to-person chains, and that has not appeared.

ECDC placed the MERS note among other steady signals in the same surveillance window, including a flat mpox clade I count . The threshold has not moved, the case pattern matches the long-running sporadic baseline, and saying so plainly is the job. A pathogen this lethal stays on the watch list precisely so that any change in its transmission behaviour is caught early rather than late.

Deep Analysis

In plain English

MERS-CoV, or Middle East Respiratory Syndrome coronavirus, is a virus related to SARS-CoV-2 (which caused COVID-19), first identified in Saudi Arabia in 2012. It lives primarily in dromedary camels and passes occasionally to humans who handle them closely. About one in three diagnosed patients dies, which is a far higher death rate than COVID-19. MERS does not spread easily between people: almost all recorded cases involve someone who caught it directly from a camel or from a hospitalised patient. Two new cases were recorded in Saudi Arabia between 4 May and 1 June 2026, one of them fatal. EU health authorities rate the risk to people in Europe as very low.

What could happen next?

Risk
MERS-CoV's approximately 35% historical CFR and continued dromedary reservoir in the Arabian Peninsula means each new case represents a surveillance obligation: any acquisition of sustained human-to-human transmissibility by this coronavirus would constitute an immediate global threat.

Source Landscape

This story draws on neutral-leaning sources from Switzerland

Switzerland

Consensus view: WHO EMRO and ECDC both assess the EU risk from MERS-CoV as very low, consistent with the established epidemiological pattern: MERS does not sustain human-to-human transmission chains in community settings. Since 2012, over 2,600 cases have been reported globally, but sustained transmission has only occurred in healthcare settings , most notably the 2015 South Korea nosocomial outbreak (186 cases, 38 deaths), which originated from a single traveller from the Arabian Peninsula.

Counter-view: The Resolve to Save Lives initiative (led by Tom Frieden) has noted that MERS surveillance in the Arabian Peninsula remains systematically incomplete: dromedary camel exposure data is not consistently gathered, and the ~35% historical CFR is partly an artefact of health-seeking behaviour in the region, where only seriously ill patients present to hospitals. The true infection fatality rate is likely lower but the denominator of total infections is genuinely unknown.

Key tension: Whether the historical 35% CFR is a stable characteristic of this coronavirus or a reporting artefact , because if it reflects genuine lethality, MERS's absence of sustained transmission is the only reason it has not become a pandemic-level threat, making any acquisition of human-to-human transmissibility a high-stakes scenario.

Sources:ECDC·WHO EMRO·WHO EMRO

Mentions:Saudi Arabia →South Korea →MERS-CoV →WHO EMRO →ECDC →Mediterranean →Tom Frieden →Resolve to Save Lives →

First Reported In

Update #6 · Ebola outbreak gets an R0, and a fork

ECDC· 9 Jun 2026

Read original →

Different Perspectives

UK Health Security Agency

UKHSA said egg consumption remains the strongest signal in its 207-case Salmonella Enteritidis investigation. The genomic cluster and 38% hospitalisation among people with available information make exposure identification a public-health priority.

GLEWS+

GLEWS+ assessed spillover risk from clade B MERS in Nile Basin camels as high if the clade establishes, while rating evidence for spread in camel populations low confidence. The joint assessment makes whole-genome sequencing the next test of the threat.

WHO Regional Office for Africa

WHO's Africa office said transmission in DR Congo is outpacing control efforts after laboratory capacity reached 19 sites and treatment capacity exceeded 1,300 beds. The assessment puts access, insecurity, community deaths and late care-seeking ahead of a simple equipment shortage.

People in Guatemala

Guatemala's population now carries the region's largest reported measles burden, with 30,371 confirmed cases and 26 deaths. The scale shifts practical attention from the Mexico-centred frame that followed the World Cup's travel consequences.

Pan American Health Organization

PAHO rated regional measles risk very high after recording 47,459 confirmed cases and 44 deaths through week 28. It names vaccination coverage, accumulated susceptibles and mass gatherings with broad international participation as general risk factors.

Chinese health authorities

China reported three human H9N2 cases to WHO between 10 and 16 July: two four-year-olds recovered, a 44-year-old man remains in intensive care, the first severity signal in a cluster that has produced 173 cases and 2 deaths globally since 2015. The subtype is distinct from the H5N1 series this topic otherwise tracks.